Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma

Name: Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma
License: Public Domain

Fudan University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hepatocellular carcinoma，bispecific antibodies, haic, ramucirumab

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 369845
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.